Calcifediol

DB00146ApprovedInvestigationalNutraceuticalSmall moleculeVitamin D and Analogues

Calcifediol is an active metabolite of vitamin D used to treat hyperparathyroidism as well as to combat hypocalcemia in dialysis patients. The major circulating metabolite of vitamin D3 (cholecalciferol).

Chemical structure of Calcifediol
Mechanism
Curator reviewed
Primary indication
Used to treat vitamin D deficiency or insufficiency, refractory rickets (vitamin D resistant rickets), familial hypophosphatemia and hypoparathyroidism, and in the management of hypocalcemia and renal osteodystrophy in patients with chronic renal failure undergoing dialysis.Curator reviewed · 2 structured indications
Formula / weight
C27H44O2 · 400.6371 g/mol (avg)
First approval
Canada, 2023 · United States, 2016
Also known as
25-hydroxycholecalciferol · 25-Hydroxyvitamin D3 · Calcidiol
Brand names
  • Rayaldee

Resolves to

Structure
InChIKeyJWUBBDSIWDLEOM-DTOXIADCSA-NSMILESC[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C
Targets

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
156Drug interactionsStructured to mechanism, not free text
Sign in
30Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
21Marketed productsAcross 6 countries and 9 labellers
Sign in
2ATC codesIncluding every combination product, plus 20 drug categories
Sign in
12+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Calcifediol, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account